United States · FDA National Drug Code directory
Carbidopa and Levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-159_bf8b1cec-9b24-4102-b948-08c988bfca91
- Product NDC
- 16571-159
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- carbidopa and levodopa
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250108
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 25 mg/1
- LEVODOPA — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (16571-159-01) · 16571-159-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →